Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage

被引：0
|
作者：
David L. Brody
Venkatesh Aiyagari
Angela M. Shackleford
Michael N. Diringer
机构：
[1] Washington University School of Medicine,Neurology/Neurosurgery Intensive Care Unit, Department of Neurology
来源：
Neurocritical Care | 2005年 / 2卷
关键词：
Intracranial hemorrhage; warfarin; coagulopathy; fresh frozen plasma; factor VIIa;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Introduction: Warfarin-associated intracranial hemorrhage (ICH) requires rapid normalization of clotting function. Current therapies are associated with significant complications and/or prolonged time to correction of coagulopathy. Recombinant factor VIIa (FVIIa) might allow faster and safer correction of coagulopathy.
引用
收藏
页码：263 / 267
页数：4
相关论文
共 50 条
  • [1] Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage
    Brody, DL
    Aiyagari, V
    Shackleford, AM
    Diringer, MN
    [J]. NEUROCRITICAL CARE, 2005, 2 (03) : 263 - 267
  • [2] Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage.
    Diringer, MN
    Aiyagari, V
    Shackleford, AM
    Brody, DL
    [J]. BLOOD, 2003, 102 (11) : 109B - 109B
  • [3] Thromboembolic risks of recombinant factor VIIa use in warfarin-associated intracranial hemorrhage
    S Chou
    X Cai
    R Konigsberg
    L Bresette
    G Henderson
    F Sorond
    A Ropper
    S Feske
    [J]. Critical Care, 15 (Suppl 1):
  • [4] SAFETY EVALUATION OF RECOMBINANT FACTOR VIIA IN WARFARIN-ASSOCIATED INTRACRANIAL HEMORRHAGE
    Rowe, Anthony
    Turner, Ryan
    [J]. CRITICAL CARE MEDICINE, 2009, 37 (12) : A70 - A70
  • [5] Recombinant factor VIIa for warfarin-associated intracranial bleeding
    Ityas, Can
    Beyer, Ginine M.
    Dutton, Richard P.
    Scatea, Thomas M.
    Hess, John R.
    [J]. JOURNAL OF CLINICAL ANESTHESIA, 2008, 20 (04) : 276 - 279
  • [6] Thromboembolic risks of recombinant factor VIIa Use in warfarin-associated intracranial hemorrhage: a case–control study
    Chou Sherry H-Y
    Cai Xuemei
    Konigsberg Rachael G
    Bresette Linda M
    Henderson Galen V
    Sorond Farzaneh A
    Feske Steven K
    [J]. BMC Neurology, 12
  • [7] Thromboembolic risks of recombinant factor VIIa Use in warfarin-associated intracranial hemorrhage: a case-control study
    Sherry, Chou H-Y
    Cai Xuemei
    Rachael, Konigsberg G.
    Linda, Bresette M.
    Galen, Henderson, V
    Farzaneh, Sorond A.
    Steven, Feske K.
    [J]. BMC NEUROLOGY, 2012, 12
  • [8] THROMBOEMBOLIC RISKS OF ACTIVATED FACTOR VIIA USE IN WARFARIN-ASSOCIATED INTRACEREBRAL HEMORRHAGE
    Chou, Sherry
    Cai, Xuemei
    Konigsberg, Rachael
    Bresette, Linda
    Henderson, Galen
    Sorond, Farzaneh
    Ropper, Allan
    Feske, Steven
    [J]. CRITICAL CARE MEDICINE, 2009, 37 (12) : A422 - A422
  • [9] WARFARIN-ASSOCIATED INTRACRANIAL HEMORRHAGE
    Yang, S. C.
    Lin, H. L.
    Chan, A. L.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A560 - A560
  • [10] Recombinant factor VIIa use in patients presenting with intracranial hemorrhage
    Yampolsky, Natalie
    Stofko, Douglas
    Veznedaroglu, Erol
    Liebman, Kenneth
    Binning, Mandy J.
    [J]. SPRINGERPLUS, 2014, 3
12345